Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079781 · ClinicalTrials.gov registry record · Phase 2
RNS® System Feasibility Study
A Phase 2 study, sponsored by NeuroPace.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00079781 is a Phase 2 study that has completed, run by NeuroPace. The registered enrollment target is 70 participants.
The verdict
NCT00079781, a Phase 2 study, has completed, sponsored by NeuroPace.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The RNS® System is intended to treat patients with medically refractory (hard to treat) epilepsy. The RNS® System Feasibility study is designed to demonstrate safety and evidence of effectiveness of the RNS® System to support the commencement of a pivotal clinical investigation.
Interventions
- PROCEDURE RNS® System implantation
- DEVICE RNS® System responsive stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00079781
The ClinicalTrials.gov registry entry for NCT00079781 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NeuroPace, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RNS® System implantation is the first listed.
NCT00079781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00079781 about?
NCT00079781 is a clinical study titled "RNS® System Feasibility Study". The RNS® System is intended to treat patients with medically refractory (hard to treat) epilepsy. The RNS® System Feasibility study is designed to demonstrate safety and evidence of effectiveness of the RNS® System to support the commencement of a pivotal clinical investigation.
What is the current status of trial NCT00079781?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2004-01. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00079781?
The interventions under investigation include: RNS® System implantation (PROCEDURE), RNS® System responsive stimulation (DEVICE).
Who is sponsoring clinical trial NCT00079781?
This trial is sponsored by NeuroPace, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.